Cite Filings / AMLX / 9999999995-25-000794

Feed Companies Filings Check

Sign in

EFFECT

Notice of Effectiveness

Amylyx Pharmaceuticals, Inc. Filed 2025-03-26 Acc 9999999995-25-000794

Documents 1

EFFECT Notice of Effectiveness , xslEFFECTX01/primary_doc.xml

Around this filing

2025-04-02 4 Chief Financial Officer sold 10,896 shares at $3.47 ($37,806)
2025-04-02 4 Chief Medical Officer sold 12,425 shares at $3.47 ($43,082)
2025-04-02 4 Chief Legal Officer sold 9,192 shares at $3.48 ($31,954)
2025-03-26 EFFECT Notice of Effectiveness
2025-03-24 CORRESP Correspondence Between Filers and SEC Staff
2025-03-24 4 Director bought 10,000 shares at $3.70 ($37,005)
2022-10-06 EFFECT Notice of Effectiveness

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslEFFECTX01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…